These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 18018484)
21. Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models. Lopes FM; Bristot IJ; da Motta LL; Parsons RB; Klamt F Neuromolecular Med; 2017 Sep; 19(2-3):241-255. PubMed ID: 28721669 [TBL] [Abstract][Full Text] [Related]
23. Progress in the clinical and molecular genetics of familial parkinsonism. Kitada T; Asakawa S; Matsumine H; Hattori N; Shimura H; Minoshima S; Shimizu N; Mizuno Y Neurogenetics; 2000 Mar; 2(4):207-18. PubMed ID: 10983716 [TBL] [Abstract][Full Text] [Related]
24. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse. Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411 [TBL] [Abstract][Full Text] [Related]
25. Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA. Konieczny J; Czarnecka A; Kamińska K; Lenda T; Nowak P Behav Brain Res; 2015 Apr; 283():203-14. PubMed ID: 25655509 [TBL] [Abstract][Full Text] [Related]
26. Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease. Dluzen DE; McDermott JL J Gend Specif Med; 2000; 3(6):36-42. PubMed ID: 11253381 [TBL] [Abstract][Full Text] [Related]
27. Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb. Vroon A; Drukarch B; Bol JG; Cras P; Brevé JJ; Allan SM; Relton JK; Hoogland PV; Van Dam AM Exp Gerontol; 2007 Aug; 42(8):762-71. PubMed ID: 17592750 [TBL] [Abstract][Full Text] [Related]
28. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease. Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279 [TBL] [Abstract][Full Text] [Related]
30. Genes, proteins, and neurotoxins involved in Parkinson's disease. von Bohlen und Halbach O; Schober A; Krieglstein K Prog Neurobiol; 2004 Jun; 73(3):151-77. PubMed ID: 15236834 [TBL] [Abstract][Full Text] [Related]
31. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Deumens R; Blokland A; Prickaerts J Exp Neurol; 2002 Jun; 175(2):303-17. PubMed ID: 12061862 [TBL] [Abstract][Full Text] [Related]
32. Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease. Boska MD; Hasan KM; Kibuule D; Banerjee R; McIntyre E; Nelson JA; Hahn T; Gendelman HE; Mosley RL Neurobiol Dis; 2007 Jun; 26(3):590-6. PubMed ID: 17428671 [TBL] [Abstract][Full Text] [Related]
33. Effects of eldepryl on glial cell proliferation and activation in the substantia nigra and striatum in a rat model of Parkinson's disease. Liu B; Lv C; Zhang J; Liu Y; Sun J; Cheng X; Mao W; Ma Y; Li S Neurol Res; 2017 May; 39(5):459-467. PubMed ID: 28276259 [TBL] [Abstract][Full Text] [Related]
34. The parkinsonian models: invertebrates to mammals. Kitamura Y; Shimohama S; Akaike A; Taniguchi T Jpn J Pharmacol; 2000 Nov; 84(3):237-43. PubMed ID: 11138723 [TBL] [Abstract][Full Text] [Related]
35. Hereditary Lewy-body parkinsonism and evidence for a genetic etiology of Parkinson's disease. Duvoisin RC; Johnson WG Brain Pathol; 1992 Oct; 2(4):309-20. PubMed ID: 1341965 [TBL] [Abstract][Full Text] [Related]
36. Neuropathology of Parkinson's disease and related syndromes. Gibb WR Neurol Clin; 1992 May; 10(2):361-76. PubMed ID: 1584179 [TBL] [Abstract][Full Text] [Related]
37. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease. Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577 [TBL] [Abstract][Full Text] [Related]